Luoting Yu

4.2k total citations
141 papers, 2.9k citations indexed

About

Luoting Yu is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Luoting Yu has authored 141 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Molecular Biology, 37 papers in Organic Chemistry and 29 papers in Oncology. Recurrent topics in Luoting Yu's work include Epigenetics and DNA Methylation (20 papers), Synthesis and biological activity (19 papers) and Cancer-related gene regulation (17 papers). Luoting Yu is often cited by papers focused on Epigenetics and DNA Methylation (20 papers), Synthesis and biological activity (19 papers) and Cancer-related gene regulation (17 papers). Luoting Yu collaborates with scholars based in China, United States and Taiwan. Luoting Yu's co-authors include Tinghong Ye, Ningyu Wang, Yuquan Wei, Yongxia Zhu, Yong Xia, Xuejiao Song, Zhuo Tang, Zhihao Liu, Qian Lei and Aiqiao Mi and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Luoting Yu

135 papers receiving 2.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Luoting Yu 1.6k 1.1k 476 201 164 141 2.9k
Sanjay Kumar Bharti 1.4k 0.9× 1.4k 1.2× 421 0.9× 237 1.2× 210 1.3× 64 3.1k
Arie Zask 1.8k 1.2× 1.3k 1.1× 550 1.2× 379 1.9× 169 1.0× 77 3.2k
Akira Asai 1.8k 1.1× 938 0.8× 649 1.4× 185 0.9× 142 0.9× 132 3.0k
Lisa Polin 1.6k 1.0× 583 0.5× 563 1.2× 363 1.8× 74 0.5× 102 3.0k
John K. Buolamwini 1.9k 1.2× 755 0.7× 728 1.5× 243 1.2× 87 0.5× 75 3.1k
Chuan Shih 1.4k 0.9× 790 0.7× 687 1.4× 175 0.9× 89 0.5× 81 2.9k
Gyoonhee Han 1.5k 0.9× 886 0.8× 474 1.0× 208 1.0× 109 0.7× 123 2.8k
Shijun Wen 2.0k 1.3× 1.2k 1.1× 511 1.1× 628 3.1× 90 0.5× 101 3.7k
Steven Fletcher 2.2k 1.4× 1.1k 0.9× 980 2.1× 180 0.9× 249 1.5× 110 3.3k
Amarnath Natarajan 1.6k 1.1× 748 0.7× 585 1.2× 187 0.9× 98 0.6× 99 2.8k

Countries citing papers authored by Luoting Yu

Since Specialization
Citations

This map shows the geographic impact of Luoting Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luoting Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luoting Yu more than expected).

Fields of papers citing papers by Luoting Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luoting Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luoting Yu. The network helps show where Luoting Yu may publish in the future.

Co-authorship network of co-authors of Luoting Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Luoting Yu. A scholar is included among the top collaborators of Luoting Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luoting Yu. Luoting Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Wei, Qi Zhang, Xin Chen, et al.. (2025). Design, synthesis and biological evaluation of 3-amino-6-(2-hydroxyphenyl)pyridazin-4-aryl derivatives as SMARCA2/4 degraders. European Journal of Medicinal Chemistry. 290. 117521–117521. 1 indexed citations
2.
Li, Siying, et al.. (2025). An updated patent review of EZH2 inhibitors (2024–present). Expert Opinion on Therapeutic Patents. 35(6). 597–610. 1 indexed citations
3.
Lu, Ye, Sichong Ren, Shuxin Yang, et al.. (2025). Simplified flow cytometry-based assay for rapid multi-cytokine profiling and machine-learning-assisted diagnosis of inflammatory diseases. Frontiers in Pharmacology. 16. 1594141–1594141.
4.
Zhou, Shuyan, et al.. (2024). Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH. Life Sciences. 342. 122538–122538. 3 indexed citations
5.
Feng, Zhanzhan, et al.. (2024). A novel selective FAK inhibitor E2 inhibits ovarian cancer metastasis and growth by inducing cytotoxic autophagy. Biochemical Pharmacology. 229. 116461–116461. 2 indexed citations
6.
Zhang, Qiangsheng, et al.. (2024). Discovery of a first-in-class degrader for the protein arginine methyltransferase 6 (PRMT6). Bioorganic Chemistry. 148. 107439–107439. 4 indexed citations
7.
Zhu, Yongxia, Lidan Zhang, Xuejiao Song, et al.. (2023). Pharmacological inhibition of EZH2 by ZLD1039 suppresses tumor growth and pulmonary metastasis in melanoma cells in vitro and in vivo. Biochemical Pharmacology. 210. 115493–115493. 3 indexed citations
8.
Hu, Xiang, Sisi Li, Qiwei Wang, et al.. (2023). TTK inhibition activates STING signal and promotes anti-PD1 immunotherapy in breast cancer. Biochemical and Biophysical Research Communications. 694. 149388–149388. 6 indexed citations
9.
Wang, Xiang, Zhiqun He, Xinyue Xu, et al.. (2023). Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis. Microbiology Spectrum. 11(5). e0472122–e0472122. 4 indexed citations
10.
Wang, Xiang, et al.. (2021). Structure-guided discovery of novel potent and efficacious proteolysis targeting chimera (PROTAC) degrader of BRD4. Bioorganic Chemistry. 115. 105238–105238. 14 indexed citations
11.
Hu, Xi, Lu Li, Qiangsheng Zhang, et al.. (2020). Design, synthesis and biological evaluation of a novel tubulin inhibitor SKLB0565 targeting the colchicine binding site. Bioorganic Chemistry. 97. 103695–103695. 13 indexed citations
12.
Tao, Xin, Zhigang Huang, Wei Luo, et al.. (2019). Discovery and evaluation of novel nitrodihydroimidazooxazoles as promising anti-tuberculosis agents. Bioorganic & Medicinal Chemistry Letters. 29(17). 2511–2515. 9 indexed citations
13.
Gao, Tiantao, Xi Hu, Qian Lei, et al.. (2018). Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis. Cancer Letters. 445. 11–23. 32 indexed citations
14.
Ye, Tinghong, Fangfang Yang, Yongxia Zhu, et al.. (2017). Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis. Cell Death and Disease. 8(1). e2534–e2534. 76 indexed citations
15.
Zhu, Yongxia, Tinghong Ye, Xi Yu, et al.. (2016). Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma. Scientific Reports. 6(1). 20253–20253. 64 indexed citations
16.
Deng, Hongxia, Jun Zeng, Yongxia Zhu, et al.. (2016). A novel small-molecule YLT256 inhibits proliferation and induces apoptosis both in vitro and in vivo in solid tumors. Biomedicine & Pharmacotherapy. 81. 482–490. 1 indexed citations
17.
Xia, Yong, Xuejiao Song, Deliang Li, et al.. (2014). YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models. Scientific Reports. 4(1). 6031–6031. 32 indexed citations
18.
Gao, Chao, Tinghong Ye, Ningyu Wang, et al.. (2013). Synthesis and structure–activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents. Bioorganic & Medicinal Chemistry Letters. 23(17). 4919–4922. 56 indexed citations
19.
Wang, Zhao, Jia Wang, Tianhua Zhou, et al.. (2011). Synthesis, structure–activity relationships and preliminary antitumor evaluation of benzothiazole-2-thiol derivatives as novel apoptosis inducers. Bioorganic & Medicinal Chemistry Letters. 21(4). 1097–1101. 58 indexed citations
20.
Zheng, Renlin, Wenqin Zhang, Luoting Yu, Shengyong Yang, & Li Yang. (2008). Ethyl 3-amino-4H-thieno[2,3-b]pyridine-2-carboxylate. Acta Crystallographica Section E Structure Reports Online. 65(1). o9–o9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanjay Kumar Bharti Breakdown of academic impact, for papers by Arie Zask Breakdown of academic impact, for papers by Akira Asai Breakdown of academic impact, for papers by Lisa Polin Breakdown of academic impact, for papers by John K. Buolamwini Breakdown of academic impact, for papers by Chuan Shih Breakdown of academic impact, for papers by Gyoonhee Han Breakdown of academic impact, for papers by Shijun Wen Breakdown of academic impact, for papers by Steven Fletcher Breakdown of academic impact, for papers by Amarnath Natarajan
Rankless by CCL
2026